Utah Medical Products (UTMD.US): The 2024 Q1 financial report achieved revenue of US$11.34 million, with a previous value of US$12.52 million; earnings per share of US$1.09, compared with a previous value of US$1.15.
Utah Medical Products(UTMD.US)：2024年Q1财报实现营收1134万美元，前值为1252万美元；每股收益为1.09美元，前值为1.15美元。
Utah Medical Products (UTMD.US): The 2024 Q1 financial report achieved revenue of US$11.34 million, with a previous value of US$12.52 million; earnings per share of US$1.09, compared with a previous value of US$1.15.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated